登录 | 注册    微信公众号  
搜索
 > 【CD37】

CD37信息

英文名称:Leukocyte antigen CD37
中文名称:白细胞抗原CD37
靶点别称:CD37,Tetraspanin-26,CD37 Molecule,CD37 Antigen,Tspan-26,TSPAN26,Cell Differentiation Antigen 37,Leukocyte Surface Antigen CD37,Leukocyte Antigen CD37,GP52-40
上市药物数量:0
临床药物数量:6
最高研发阶段:临床二期

CD37产品列表

 
评论(1)
CD7-H52H3|Human CD37 Protein, His Tag
  1. 166XXXXXXX6
  2. 1人赞
  3. 该样品是我们公司用来进行免疫方案设计的刚需产品,刚通过了我们公司的质检,纯度和活性检测均达到免疫要求,对您公司的蛋白我们也是经常合作,产品质量也是十分认可,以后依然会推荐购买~合作愉快。
  4. 2022-01-31
 

CD37 分子别名

CD37,Tspan-26,TSPAN26

CD37 分子背景

Leukocyte antigen CD37 (CD37) is also known as Tetraspanin-26 (Tspan-26) and TSPAN26,which is a member of the transmembrane 4 superfamily or tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins encoded by CD37 gene mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. CD37 is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. CD37 may play a role in T-cell-B-cell interactions.

CD37 前沿进展

CD37临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CAR-37 T cell therapy (Massachusetts General Hospital) 临床一期 Massachusetts General Hospital 白血病, B-细胞淋巴瘤, 血液肿瘤, 淋巴瘤, 非霍奇金淋巴瘤, T-细胞淋巴瘤 详情
AGS-67E AGS-67E 临床一期 Agensys 毛细胞白血病, 淋巴细胞性白血病, 急性髓细胞样白血病, 非霍奇金淋巴瘤, 慢性淋巴细胞白血病 详情
Lutetium (177lu) lilotomab satetraxetan 177Lu-DOTA-HH1 临床二期 Nordic Nanovector B-细胞淋巴瘤, 弥漫性大B-细胞淋巴瘤, 滤泡中心淋巴瘤, 非霍奇金淋巴瘤 详情
BI-836826 mAb-37.1; mAb-37.2; BI-836826 临床二期 勃林格殷格翰 弥漫性大B-细胞淋巴瘤, 非霍奇金淋巴瘤, 慢性淋巴细胞白血病 详情
Naratuximab emtansine IMGN-529; K7153A-SMCC-DM1 临床二期 Immunogen B-细胞淋巴瘤, 弥漫性大B-细胞淋巴瘤, 非霍奇金淋巴瘤, 慢性淋巴细胞白血病 详情
Ivicentamab GEN-3009 临床二期 Genmab, 艾伯维 B-细胞淋巴瘤, 非霍奇金淋巴瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定